Results 21 to 30 of about 5,768 (99)
Background: Intra-abdominal adhesions after surgery are usually in the form of bands and can annoy the patient throughout life causing repeated surgical procedures.
Ali Hosseini+3 more
doaj +1 more source
Fermentation, fractionation and purification of streptokinase by chemical reduction method
Background and Objectives: Streptokinase is used clinically as an intravenous thrombolytic agent for the treatment of acute myocardial infarction and is commonly prepared from cultures of Streptococcus equisimilis strain H46A.
Z Karimi+4 more
doaj
The efficacy and safety of thrombolytic agents for patients with prosthetic valve thrombosis
Introduction: Prosthetic valve thrombosis (PVT) is a serious complication seen with mechanical prosthetic cardiac valves and is associated with high mortality.
Vinod Sharma+7 more
doaj +1 more source
Evaluation of In vivo Bioactivity of a Mutated Streptokinase
Background: Immunogenicity of Streptokinase, as a thrombolytic drug, has limited its clinical use. Elimination of the amino acid residues that are responsible for immunogenicity while don’t affect the bioactivity of streptokinase is worthy. Recently, we
Marzieh Sameni+6 more
doaj
Background & aim: Myocardial infarction is one of the most common cardiovascular diseases. Streptokinase is used in patients with myocardial infarction with ST-segment elevation.
M Behnam Moghadam+4 more
doaj
Abnormal chest x-ray postmyocardial infarction
Pulmonary hemorrhage is a rare complication of fibrinolytic therapy. Only a few cases are reported in the literature. We present a patient who had myocardial infarction, treated with fibrinolytic therapy and developed pulmonary hemorrhage. We discuss the
Ahmed M Abuosa+2 more
doaj +1 more source
Background: The risk for unsuccessful reperfusion after streptokinase therapy may be caused by the antifibrinolytic effect of platelet-derived type 1 plasminogen activator inhibitor (Pal-1) and antistreptokinase antibodies.
H Shemirani+3 more
doaj
Aim. To study effects of various streptokinase thrombolytic therapy (TLT) and following antithrombotic therapy variants on coagulation hemostasis and fibrinolysis parameters; to prove the opportunity to use reduced streptokinase doses in acute myocardial
Ya. L. Gabinsky, S. G. Kalinina
doaj
Imtinene Ben Mrad,1 Melek Ben Mrad,2 Zeineb Oumaya,1 Ihsen Zairi,1 Boutheina Besbes,1 Khalil Ouaghlani,1 Sofien kamoun,1 Sobhi Mleyhi,2 Rim Miri,2 khadija Mzoughi,1 Sondos Kraiem1 1Cardiology Department, Habib Thameur Hospital, Tunis, Tunisia ...
Ben Mrad I+10 more
doaj
Rationale: Acute myocardial infarction in the presence of right bundle branch block. Patient concerns: A 70-year-old, male heavy smoker presented with angina and hypertension.
Yasser Mohammed Hassanain Elsayed
doaj +1 more source